Clinical Trials for Diffuse Large B-cell Lymphoma Recurrent

Find clinical trials for diffuse large b-cell lymphoma recurrent. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL

NCT ID: NCT06086197

This clinical trial is investigating a new combination treatment called A-RGEMOX for patients with diffuse large B-cell lymphoma (DLBCL) who have experienced an early relapse or have not responded ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, Zhejiang, China

Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL

NCT ID: NCT06033820

This clinical trial is studying a new treatment approach for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a type of blood cancer. The treatment involves a combination...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions